M
$ Value
—
Shares
26,750
Price
—
Filed
Dec 4
Insider
Name
Davis Hugh M.
Title
President and COO
CIK
0002045027
Roles
Director
Officer
Transaction Details
Transaction Date
2025-12-02
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
26,750
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of December 2, 2024 (in each case rounded down to the nearest whole share, except for the last vesting installment), subject to the Continuous Service (as defined in the Issuer's 2024 Inducement Plan) of the Reporting Person as of each such date.
Filing Info
Davis Hugh M.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | ACRS | M | — |
| 2026-02-03 | ACRS | M | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2025-12-02 | ACRS | M | — |
| 2025-12-02 | ACRS | M | $0 |
Other Insiders at ACRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walker Neal
CEO
|
— | — | 2026-02-03 |
|
Loerop James
Chief Business Officer
|
— | — | 2026-02-03 |
|
Balthaser Kevin
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Davis Hugh M.
President and COO
|
— | — | 2026-02-03 |
|
Hall Jesse Wayne
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Kolbeck Roland Wilhelm
Chief Scientific Officer
|
— | — | 2026-02-02 |